Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A. - Wikidata - awgldk - TriplyDB

Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.

Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.

http://www.wikidata.org/entity/Q38875552

about

Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.Inhibitory effect of Par-4 combined with cisplatin on human Wilms' tumor cells.Natural Withanolides in the Treatment of Chronic Diseases.AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stress Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model.Regiospecific Synthesis of Ring A Fused Withaferin A Isoxazoline Analogues: Induction of Premature Senescence by W-2b in Proliferating Cancer Cells.Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.

P2860

Q28555025-96FC9FB5-17C0-4C2D-A737-8DC696AEF661 Q36135798-B156D4A2-F52D-4801-A3EC-0DF09D199245 Q36427985-F8393E08-8186-4C1B-ACA8-AF5A60E76DE8 Q38559343-A4016F12-D06C-40C9-B1E7-51746C113ED3 Q38696904-7B90B0F6-D980-4F37-A871-A6A2064A13CD Q38965226-BD274B69-D78F-42D5-AD0A-22CD0EFDD434 Q41098523-FD56E081-94AB-44EA-9853-17731B45697C Q42137006-C88F8352-FD1D-474F-BA0F-EEF2AB691269 Q45854100-A94DC056-099D-49AC-B7E5-874FA6F2582C Q50643738-4CA9181A-6B73-44CD-ACEF-5DF8D9916C76

P2860

Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.

http://www.wikidata.org/entity/Q38875552

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Par-4 dependent modulation of ...... rivative 3-azido Withaferin A.

@en

type

label

Par-4 dependent modulation of ...... rivative 3-azido Withaferin A.

@en

prefLabel

Par-4 dependent modulation of ...... rivative 3-azido Withaferin A.

@en

P1433

Q38875552-5E9FE36E-20E3-4DCA-A036-D15C8A3AA105

P1476

Q38875552-032C82C7-0381-4821-8221-460A2231506A

P2093

Q38875552-17B9EA84-928D-4F7C-ACB4-36FA6B936B16

Q38875552-2961E445-F165-4605-A220-B41576272D18

Q38875552-2FA14875-E243-4E69-970B-E7C6CC9BDE27

Q38875552-3236E3A0-FC4D-44B9-A071-F800A0913F3C

Q38875552-3AEDBD4A-1658-4261-922E-516503C65676

Q38875552-3BD5DC97-E372-4D15-B19B-098D1BE1AFF9

Q38875552-93A2D8D0-6F03-49BB-8831-34361AA08C45

Q38875552-9A5ADDED-38C6-484B-9AA0-3DE945BC91B0

Q38875552-B0586AA8-A645-4C98-BE56-7F820ECBB5F3

Q38875552-BC74EB6B-52CF-47CF-9D2C-721BC316FDE8

P2860

Q38875552-16D5BFA5-1009-4EFC-8699-0F83BBBCADEB

Q38875552-2F3FC5DD-5F9B-4410-A9BD-7CB2558831A3

Q38875552-35025E72-F0A3-4B95-9DC1-8D34E33F6E25

Q38875552-3DFDCF07-AB68-429F-9849-85E9707C6B47

Q38875552-3E73F3D9-6441-4F27-A049-4071EEFD891C

Q38875552-40C77524-CCE0-481B-A1D3-85EEC6A058EC

Q38875552-43E2CE32-6976-4A71-8A91-38A86E654EF4

Q38875552-5298CC3F-F176-4586-8221-BC201C3E1EB9

Q38875552-5412A972-A394-4B07-B11A-283DEFAFEA1B

Q38875552-559C14E5-204C-409B-81DB-EB6D1BF29108

P304

Q38875552-27B1C8BD-E8FD-48F6-8A41-DED5E4031781

P31

Q38875552-A6A908F3-D0CE-43E4-A230-303E8E39C636

P356

Q38875552-E6D6E176-DA5D-4740-9F71-52E674CEA180

P433

Q38875552-7779E58D-4FF4-47E2-A519-F0B83054475D

P478

Q38875552-D4EA1813-6A15-4501-B636-5CFBBDD6C489

P577

Q38875552-87F22A99-4257-43A8-98DC-5B56B2D4D153

P698

Q38875552-432C2EDD-D573-4B4D-9981-9AC96F5DBFE8

P356

P1433

Molecular Carcinogenesis

P1476

Par-4 dependent modulation of ...... rivative 3-azido Withaferin A.

@en

P2093

Anindya Goswami

http://www.w3.org/2001/XMLSchema#string

Anmol Kumar

http://www.w3.org/2001/XMLSchema#string

Asmita Magotra

http://www.w3.org/2001/XMLSchema#string

Debaraj Mukherjee

http://www.w3.org/2001/XMLSchema#string

Debasis Nayak

http://www.w3.org/2001/XMLSchema#string

Hina Amin

http://www.w3.org/2001/XMLSchema#string

Khalid Yousuf

http://www.w3.org/2001/XMLSchema#string

Lekha Dinesh Kumar

http://www.w3.org/2001/XMLSchema#string

Neelam Sharma

http://www.w3.org/2001/XMLSchema#string

Parduman Raj Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis

Molecular pathology of prostate cancer

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway

Role of prostaglandins in acute phase proteins in inflammation

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

P304

864-881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.22328

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25969134

http://www.w3.org/2001/XMLSchema#string